Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma
1 clinical trials · Condition
◉ Watch Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer (NCT04585958) | National Cancer Institute (NCI) | 2021-05-21 |
Track Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.